NovoCure

-$6.03 (-5.44%) As of 2:21 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.

CEO
Asaf Danziger
Employees
1,023
Headquarters
St. Helier, Jersey
Founded
2000

NVCR Key Statistics

Market Cap
10.86B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
412.31K
High Today
$106.24
Low Today
$100.05
Open Price
$106.00
Volume
345.66K
52 Week High
$232.76
52 Week Low
$100.05

NVCR News

Benzinga3h

Recap: NovoCure Q3 Earnings

NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM. Here's what investors need to know about the announcement.

NVCR Earnings

-$0.14
-$0.05
$0.03
$0.12
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
-$0.07 per share
Actual
-$0.13 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure